The sensitivity of T. cruzi to azoles, potent inhibitors of CYP51 used to treat fungal infections, led to the assumption that ergosterol synthesis is essential for T. cruzi growth and survival (Lepesheva et al., 2018; Osorio-Méndez and Cevallos, 2018). The gene discussed is CYP51A1; the disease is fungal infectious disease.